CRISPR/Cas9-related technologies in liver diseases: from feasibility to future diversity

Liver diseases are one of the leading causes of mortality in the world, mainly caused by different etiological agents, alcohol consumption, viruses, drug intoxication, and malnutrition. The maturation of gene therapy has heralded new avenues for developing effective interventions for these diseases....

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Biol Sci
Главные авторы: Xu, Tao, Li, Li, Liu, Yu-chen, Cao, Wei, Chen, Jia-si, Hu, Shuang, Liu, Ying, Li, Liang-yun, Zhou, Hong, Meng, Xiao-ming, Huang, Cheng, Zhang, Lei, Li, Jun, Zhou, Huan
Формат: Artigo
Язык:Inglês
Опубликовано: Ivyspring International Publisher 2020
Предметы:
Review
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7378651/
https://ncbi.nlm.nih.gov/pubmed/32760197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.33481
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы